Request Trial
mrinalpal / Shutterstock.com
4 June 2026NewsCareersMarisa Woutersen

Chadha & Chadha hires former Remfry & Sagar patent partner

The Indian firm has added a partner who brings more than three decades of experience advising clients across the pharmaceuticals, life sciences, technology and manufacturing sectors.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Cooley Asia transactions duo make rival firm move
23 June 2026   The pair bring a strong track record advising life sciences companies on licensing, collaboration and commercialisation agreements, with a particular focus on cross-border biotech transactions.
Careers
Quantum and photonics tech licensing expert joins EIP
18 June 2026   With more than 25 years of experience as a commercial and IP lawyer, the firm’s new partner previously led the legal function at a pioneering UK company.
Careers
Ex-Simmons head of IP joins Carpmaels & Ransford
15 June 2026   Highly experienced partner is the second big name to join the firm this year, expanding its Engineering & Tech practice and beefing up its IP disputes work.


Editor's picks

Hikma v Amarin: Six takeaways from the pivotal ruling
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026

Editor's picks

Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026

More features

Cooley Asia transactions duo make rival firm move
Insilico lands potential $2.5bn AI biotech partnership
‘Blatant imitation’: Indian court blocks copycat pharma branding
UPC hands Occlutech second win against Chinese medtech company in a month
US life sciences damages averaged $33.5m between 2019-2025
Quantum and photonics tech licensing expert joins EIP
Court upholds $83m sequencing verdict and sets royalty rate
Exclusive: ‘Cultural differences are an asset’ at the UPC